CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Inflammatory Bowel Disease

lycera

Lycera Achieves First Milestone in Merck Research Collaboration

Lycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.

WWJ Newsradio 950–12/21/2011

lycera

Lycera Graduates from Incubator to North Campus Research Complex

Lycera, a biopharmaceutical company and University of Michigan spinoff, plans to partner and collaborate with U-M faculty and students with a move to UM’s North Campus Research Complex.

WWJ Newsradio 950–06/09/2011

nephrx

NephRx Gets Patent For Peptide In Inflammatory Bowel Disease

Kalamazoo-based NephRx Corp. has been issued of a United States patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.

03/24/2011

lycera

Lycera Announces Research Collaboration with Merck

The Plymouth-based biopharmaceutical developer Lycera Corp. Thursday announced an exclusive research collaboration with pharma giant Merck to develop drug candidates that have the potential to treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis

03/03/2011

Follow

Get every new post delivered to your Inbox.

Join 1,927 other followers